(1 - 21 from 32
)
#NACFC Promising Data on CF Inhaled Antifungal Therapy to Be...
cysticfibrosisnewstoday.com
Read about Pulmatrix's presentation at NACFC 2016, detailing positive preclinical data on its inhaled antifungal therapy PUR1900 for CF lung infections.
(PULM) - Pulmatrix Issued Patents Covering iSPERSE Technology for...
www.benzinga.com
Pulmatrix Issued Patents Covering iSPERSE Technology for Treatment of Patients ... of the iSPERSE™ technology," said David Hava, ... Benzinga is a fast-growing ...
European Clinical Trial Enrolling Patients for COPD Treatment - Lung...
lungdiseasenews.com
Read about Pulmatrix's European pilot bioequivalence study of PUR0200 for the treatment of COPD that is currently enrolling participants.
COPD Bronchodilator Treatment Now Recruiting for European...
copdnewstoday.com
Read about a COPD European pilot bioequivalence study on Pulmatrix's PUR0200 currently recruiting participants.
sorted by relevance / date